by plexusventures_h3tnl0 | Jan 9, 2015 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful completion of its 10th product divestment for Novartis AG. Plexus provided professional services to Novartis Consumer Health, Inc. in the divestiture of U.S. commercial rights to...
by plexusventures_h3tnl0 | Sep 15, 2014 | Uncategorized
Philadelphia, PA – Plexus Ventures LLC, a leading global pharmaceutical business development consultancy, announced today that Dr. Chika Yoshinaga has joined the firm as Senior Consultant. Dr. Yoshinaga comes to Plexus Ventures with a breadth of experience in...
by plexusventures_h3tnl0 | Mar 20, 2013 | Uncategorized
“Los Angeles, California — Plexus Ventures is pleased to announce the successful completion of a recent divestment project. Plexus provided professional services to the seller in their divestment of the Zyma® Brands to Rottapharm | Madaus in 19 countries...
by plexusventures_h3tnl0 | Dec 18, 2012 | Uncategorized
London, United Kingdom — Plexus Ventures is pleased to announce the conclusion of a successful divestment assignment for Novartis Consumer Health (Switzerland), for which Plexus Ventures acted as exclusive external advisor. Novartis recently sold the rights to...
Recent Comments